Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,074 across all filing types
Latest filing 2022-11-21 Board/Management Inform…
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Vivesto appoints Erik Kinnman as CEO
Board/Management Information Classification · 98% confidence The document is a short announcement titled 'Vivesto appoints Erik Kinnman as CEO' detailing a change in senior management (the appointment of a new CEO). This directly aligns with the definition for Board/Management Information (MANG). The document length is short (2649 chars), but the content is the announcement itself, not a notice about an attached report, so RPA/RNS is less appropriate than the specific content classification.
2022-11-21 English
Valberedning utsedd inför Vivestos årsstämma 2023
AGM Information Classification · 95% confidence The document is titled "Valberedning utsedd inför Vivestos årsstämma 2023" (Nomination Committee appointed ahead of Vivesto's Annual General Meeting 2023). It details the composition of the nomination committee based on ownership structure as of September 30, 2022, and mentions the date of the upcoming AGM (May 25, 2023). This content directly relates to the preparation and governance surrounding the Annual General Meeting (AGM). While it is an announcement about the AGM process, it is not the proxy statement (PSI) or the voting results (DVA). It is most closely related to the general information provided for the AGM. Since there is no specific code for 'Nomination Committee Appointment', and the content is directly tied to the AGM process, AGM-R (AGM Information) is the most appropriate classification, as these appointments are key components of the AGM preparation materials.
2022-11-21 Swedish
Nomination Committee appointed for the 2023 Annual General Meeting in Vivesto
AGM Information Classification · 98% confidence The document explicitly announces the appointment of the Nomination Committee for the upcoming 2023 Annual General Meeting (AGM). It details the members appointed based on ownership structure and sets the date for the AGM (May 25, 2023). This content directly relates to the preparatory and administrative aspects of the Annual General Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). The document is not a full report (10-K, IR), a proxy statement (DEF 14A/PSI), or just a general regulatory announcement (RNS), but specifically concerns the AGM process.
2022-11-21 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Vivesto AB for the period 1 January to 30 September 2022. It contains comprehensive financial data, including income statements, balance sheet items, and management commentary on business performance, R&D, and product pipelines. It is clearly a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-17 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for the period January 1, 2022 – September 30, 2022' and contains detailed financial statements, including consolidated net sales, operating profit/loss, and earnings per share for the third quarter and the nine-month period. It also includes a management review from the acting CEO and updates on business operations. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2022
2022-11-17 English
Christer Nordstedt avgår som tillförordnad VD för Vivesto
Board/Management Information Classification · 100% confidence The document is a formal announcement in Swedish stating that the interim CEO, Christer Nordstedt, has resigned to take a new position outside the company, but will remain as a senior advisor. This directly concerns a change in senior management. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is short and serves as a direct announcement of this personnel change, making MANG the most appropriate classification.
2022-11-03 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.